Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
25.6%
% of HRTS's 39 holdings also in AGNG
12.2%
% of AGNG's 82 holdings also in HRTS
Overlap by Weight
Sector Drift (HRTS minus AGNG)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in AGNG |
Overlap | |
|---|---|---|---|---|
 |
CHUGAI PHARMACEUTICAL CO LTD | 3.6% | 3.8% | 3.6% |
 |
AMGEN INC | 8.0% | 3.3% | 3.3% |
|
ELI LILLY & CO | 4.9% | 3.0% | 3.0% |
|
BOSTON SCIENTIFIC CORP | 2.9% | 3.5% | 2.9% |
 |
MEDTRONIC PLC | 2.7% | 2.9% | 2.7% |
Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to AGNG
|
VERTEX PHARMACEUTICALS INC | 5.7% |
|
ALNYLAM PHARMACEUTICALS INC | 5.0% |
|
AMGEN INC | 4.7% |
|
BRIDGEBIO PHARMA, INC. | 3.9% |
|
CRINETICS PHARMACEUTICALS INC | 3.9% |
|
CYTOKINETICS INC | 3.5% |
 |
ASTRAZENECA PLC | 2.9% |
|
IONIS PHARMACEUTICALS, INC. | 2.4% |
|
MASIMO CORPORATION | 2.3% |
|
ASCENDIS PHARMA A/S | 2.2% |
HRTS Underweight Relative to AGNG
|
WELLTOWER, INC. | -4.2% |
|
ABBVIE INC | -3.3% |
 |
UCB SA | -3.2% |
 |
ALCON, INC. | -3.1% |
|
BRISTOL-MYERS SQUIBB CO | -3.0% |
|
STRYKER CORP | -3.0% |
|
JOHNSON & JOHNSON | -2.9% |
|
ROCHE HOLDING AG-BR | -2.8% |
|
ASTRAZENECA PLC-SPONS ADR | -2.5% |
|
TERUMO CORP | -2.5% |